Acute HIV infection is associated with a vigorous immune response characterized by the proliferation of selected T cell receptor V beta (BV)-expressing CD8+ T cells. These ‘expansions', which are commonly detected in the peripheral blood, can persist during chronic HIV infection and may result in the dominance of particular clones. Such clonal populations are most consistent with antigen-driven expansions of CD8+ T cells. However, due to the difficulties in studying antigen-specific T cells in vivo, it has been hard to prove that oligoclonal BV expansions are actually HIV specific. The use of tetrameric major histocompatibility complex–peptide complexes has recently enabled direct visualization of antigen-specific T cells ex vivo but has not provided information on their clonal composition. We have now made use of these tetrameric complexes in conjunction with anti-BV chain–specific monoclonal antibodies and analysis of cytotoxic T lymphocyte lines/clones to show that chronically clonally expanded CD8+ T cells are HIV specific in vivo.
Skip Nav Destination
Article navigation
17 August 1998
Brief Definitive Report|
August 17 1998
Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific
Jamie D.K. Wilson,
Jamie D.K. Wilson
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Graham S. Ogg,
Graham S. Ogg
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Rachel L. Allen,
Rachel L. Allen
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Philip J.R. Goulder,
Philip J.R. Goulder
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Anthony Kelleher,
Anthony Kelleher
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Andy K. Sewell,
Andy K. Sewell
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Christopher A. O'Callaghan,
Christopher A. O'Callaghan
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Sarah L. Rowland-Jones,
Sarah L. Rowland-Jones
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Margaret F.C. Callan,
Margaret F.C. Callan
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Andrew J. McMichael
Andrew J. McMichael
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Jamie D.K. Wilson
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Graham S. Ogg
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Rachel L. Allen
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Philip J.R. Goulder
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Anthony Kelleher
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Andy K. Sewell
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Christopher A. O'Callaghan
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Sarah L. Rowland-Jones
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Margaret F.C. Callan
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Andrew J. McMichael
From the Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom
Address correspondence to J.D.K. Wilson, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK. Phone: 44-1865-222-334; Fax: 44-1865-222-502; E-mail: [email protected]
Received:
May 08 1998
Revision Received:
June 02 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (4): 785–790.
Article history
Received:
May 08 1998
Revision Received:
June 02 1998
Citation
Jamie D.K. Wilson, Graham S. Ogg, Rachel L. Allen, Philip J.R. Goulder, Anthony Kelleher, Andy K. Sewell, Christopher A. O'Callaghan, Sarah L. Rowland-Jones, Margaret F.C. Callan, Andrew J. McMichael; Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific . J Exp Med 17 August 1998; 188 (4): 785–790. doi: https://doi.org/10.1084/jem.188.4.785
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement